The result indicates that CD90 vascular immunostaining could distinguish PDAC from non-malignant pancreatic tissues and the overexpression of CD90 in tumor vasculature of PDAC may play a role in angiogenesis in pancreatic adenocarcinoma. Here, THY1 is linked to pancreatic adenocarcinoma.